Novartis, staring down tough market for M&A, leans toward $25B Sandoz spinoff: Bloomberg
1st July 2022 Uncategorised 0 Novartis, staring down tough market for M&A, leans toward $25B Sandoz spinoff: Bloomberg
fkansteiner
Fri, 07/01/2022 – 08:33
More: Novartis, staring down tough market for M&A, leans toward B Sandoz spinoff: Bloomberg
Source: fierce